Interleukin-27: Can a cytokine with both pro and anti-inflammatory activity make a good drug target?

Interleukin-27: Can a cytokine with both pro & anti-inflammatory activity make a good drug target?
Credit: Mary Ann Liebert, Inc., publishers

Interleukin-27 (IL-27), a member of the interleukin family of cytokines that help regulate the immune system, has a mainly anti-inflammatory role in the body, and its dysfunction has been implicated in autoimmune diseases such as multiple sclerosis and Crohn's disease. More recently, IL-27's proinflammatory activity and role in chronic inflammatory diseases is becoming increasingly clear, and a new Review article that explores the potential to target a range of diseases that share common IL-27-activated mechanisms is presented in Journal of Interferon & Cytokine Research (JICR).

Christopher Wynick, Carlene Petes, and Katrina Gee, Queen's University, Kingston, Canada, explain how IL-27 can contribute to the control of both anti- and proinflammatory responses depending on the predominant type of immune response elicited in the body, the disease type, and the disease severity. They focus primarily on the proinflammatory activity of the cytokine in the article "Interleukin-27 Mediates Inflammation During Chronic Disease".

"IL-27 is emerging as a significant determinant of the character of inflammatory response and this review provides an important perspective," says Co-Editor-in-Chief Thomas A. Hamilton, PhD, Chairman, Department of Immunology, Cleveland Clinic Foundation, Ohio.


Explore further

Pattern recognition receptors may be potent new drug targets for immune-mediated diseases

More information: The article is available free on the JICR website until November 20, 2014.
Citation: Interleukin-27: Can a cytokine with both pro and anti-inflammatory activity make a good drug target? (2014, October 20) retrieved 15 December 2019 from https://medicalxpress.com/news/2014-10-interleukin-cytokine-pro-anti-inflammatory-good.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments